ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.00%
Bitcoin
66,866.87
-0.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) News

ORGS

Orgenesis (ORGS)

Orgenesis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORGS
DateTimeSourceHeadlineSymbolCompany
05/15/20243:01PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ORGSOrgenesis Inc
05/06/20242:30PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORGSOrgenesis Inc
05/06/20242:28PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ORGSOrgenesis Inc
05/06/20242:26PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORGSOrgenesis Inc
04/15/20244:07PMGlobeNewswire Inc.Orgenesis Provides Year End Business UpdateNASDAQ:ORGSOrgenesis Inc
04/10/202411:00AMGlobeNewswire Inc.Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityNASDAQ:ORGSOrgenesis Inc
03/18/20247:30AMGlobeNewswire Inc.Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceNASDAQ:ORGSOrgenesis Inc
03/13/20247:30AMGlobeNewswire Inc.Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesNASDAQ:ORGSOrgenesis Inc
03/04/20247:30AMGlobeNewswire Inc.Orgenesis Inc. Announces $2.3 Million Private PlacementNASDAQ:ORGSOrgenesis Inc
02/29/20247:30AMGlobeNewswire Inc.Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingNASDAQ:ORGSOrgenesis Inc
01/31/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/31/20248:15AMGlobeNewswire Inc.Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicNASDAQ:ORGSOrgenesis Inc
01/24/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/22/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/08/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
01/08/20244:36PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
01/05/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
11/14/20237:30AMGlobeNewswire Inc.Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNASDAQ:ORGSOrgenesis Inc
11/13/20233:15PMGlobeNewswire Inc.Orgenesis Provides Business Update for the Third Quarter of 2023NASDAQ:ORGSOrgenesis Inc
11/13/20233:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
11/09/20236:41AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ORGSOrgenesis Inc
11/08/20238:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
11/08/20238:00AMGlobeNewswire Inc.Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNASDAQ:ORGSOrgenesis Inc
11/02/20237:00AMGlobeNewswire Inc.Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant FundingNASDAQ:ORGSOrgenesis Inc
10/30/20238:30PMGlobeNewswire Inc.Orgenesis Announces Withdrawal of Proposed Public OfferingNASDAQ:ORGSOrgenesis Inc
10/30/20233:07PMGlobeNewswire Inc.Orgenesis Announces Proposed Underwritten Public OfferingNASDAQ:ORGSOrgenesis Inc
09/21/20237:00AMGlobeNewswire Inc.CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United StatesNASDAQ:ORGSOrgenesis Inc
09/08/20233:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ORGSOrgenesis Inc
09/06/20236:00AMGlobeNewswire Inc.Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service SupportNASDAQ:ORGSOrgenesis Inc
09/05/20233:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
 Showing the most relevant articles for your search:NASDAQ:ORGS

Your Recent History

USOTC
FSRN
Fisker (PK)
NASDAQ
CRKN
Crown Electrokinetics
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
CLNV
Clean Vision (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
GWAV
Greenwave Technology Sol...
USOTC
MGON
Megola (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
PHIL
PHI (PK)
USOTC
FDCT
FDCTech (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
GNCP
GNCC Capital (CE)
NASDAQ
JAGX
Jaguar Health
USOTC
CYDY
CytoDyn (QB)
USOTC
CBIA
Canopus Biopharma (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved